Labcorp Holdings Inc. Files 8-K Report

TL;DR

Labcorp filed an 8-K, standard procedure, nothing major to see here yet.

AI Summary

On September 16, 2024, LABCORP HOLDINGS INC. filed an 8-K report detailing other events and financial statements. The filing was made public on September 18, 2024, and pertains to the company's operations as of September 16, 2024. No specific financial transactions or significant events were detailed in the provided excerpt.

Why It Matters

This filing indicates that Labcorp Holdings Inc. is fulfilling its regulatory reporting obligations with the SEC, providing transparency to investors about its corporate activities.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not disclose any immediate negative or positive material events.

Key Numbers

• 20240916 — Report Date (Date of earliest event reported)
• 20240918 — Filing Date (Date the report was filed with the SEC)

Key Players & Entities

• LABCORP HOLDINGS INC. (company) — Registrant
• 0000920148 (company) — Central Index Key
• 358 South Main Street, Burlington, North Carolina 27215 (company) — Principal executive offices address
• 336-229-1127 (company) — Registrant's telephone number

FAQ

From the Filing

0001193125-24-221373.txt : 20240918 0001193125-24-221373.hdr.sgml : 20240918 20240918160559 ACCESSION NUMBER: 0001193125-24-221373 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240916 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240918 DATE AS OF CHANGE: 20240918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 241307506 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 d863377d8k.htm 8-K 8-K false 0000920148 0000920148 2024-09-16 2024-09-16     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2024     LABCORP HOLDINGS INC. (Exact name of registrant as specified in Charter)       Delaware (Labcorp Holdings Inc.)   1-11353   99-2588107 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   358 South Main Street , Burlington , North Carolina   27215 (Address of principal executive offices)   (Zip Code) 336 - 229-1127 Registrant’s telephone number, including area code N/A (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.10 par value   LH   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. The Underwriting Agreement On September 16, 2024, Laboratory Corporation of America Holdings (the “Issuer”), the wholly owned subsidiary of Labcorp Holdings Inc. (the “Company”), and the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with BofA Securities, Inc., U.S. Bancorp Investments, Inc., and Wells Fargo Securities, LLC, as representatives of the several underwriters named there